NCT07361705 2026-01-23
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 1 Not yet recruiting
Clinical Trials
6 trialsNCT06304441 2025-09-29
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Guangzhou Medical University
Phase NA Recruiting
NCT04233021 2025-02-03
ORBITAL
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Completed
NCT02228369 2021-01-05
BLOOM
AstraZeneca
Phase 1 Completed
NCT04425681 2020-06-11
OWBLM
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown
NCT04148898 2019-11-04
OWONBNSCLCLM
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown